Huperzine A
Studied for: Neurodegeneration
Neurodegeneration
What the research found
Yielded measurable cognitive benefits through acetylcholinesterase inhibition, improving short-term cognitive scores, exhibiting a favorable tolerability profile comparable to conventional therapies.
Dose used in studies
administered at 400 µg daily
Side effects reported
mild nausea and dissiness
References
Gualtieri2025 (https://consensus.app/papers/exploring-the-efficacy-and-safety-of-nutritional-gualtieri-frank/0427caa6114b56b18688096037b921f4/), De Lima2025 (https://consensus.app/papers/polyphenols-alkaloids-and-terpenoids-against-lima-laurindo/6482f35231d859c7aa68bfb81cc70eed/), Lerose2024 (https://consensus.app/papers/withania-somnifera-l-dunal-a-potential-source-of-lerose-ponticelli/3fb5927e7b30513987bde1028ce83f75/)
Not medical advice
Trials are run on specific people, for specific reasons, over a set period. Your medications, conditions and bloodwork can change what is safe for you. Ask a doctor or pharmacist before starting.